The story of Viagra and the pharmaceutical industry presents a intricate picture for prospective investors. Initially, copyright's blockbuster drug altered the treatment of erectile dysfunction, generating significant profits and shaping the contemporary pharmaceutical landscape. However, intellectual property expiration and the appearance of off-b